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(57)	 ABSTRACT
A blood monitoring system is capable of monitoring the
blood of a subject in vivo. The blood monitoring system
comprises: 1) an array of movable microneedle microma-
chined within associated wells; 2) array of motion actuators
able to move each needle in and out of their associated wells;
3) array of microvalves associated with each microneedle
able to control the flow of air around the microneedle; 4) an
array of chemical sensors inserted into patient by movable
microneedles; 5) an array of inductors able to measure chemi-
cal concentration in the vicinity of inserted chemical sensors;
6) conducting vias that provide timed actuating signal signals
from a control system to each motion actuator; 7) conducting
vias that transmit signal produced by array of chemical sen-
sors to the control system for processing, although the blood
monitoring system can comprise other numbers and types of
elements in other configurations.
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BLOOD MONITORING SYSTEMS AND
METHODSTHEREOF
CROSS REFERENCE TO RELATED
APPLICATIONS
This application claims the benefit of U.S. Provisional
Application No. 60/670,150 filed Apr. 11, 2005, the entire
disclosure of which is incorporated herein by reference.
GOVERNMENT SPONSORSHIP
This invention was made with government support under
Grant NAG3-2744 awarded by NASA. The Government has
certain rights in the invention.
FIELD OF THE INVENTION
This invention relates to blood monitoring systems and
methods thereof.
BACKGROUND
Microneedle technology provides a useful minimally-in-
vasive method to sample blood. Due to their small size,
microneedles can pierce skin and take minute quantities of
blood with minimal impact and orpain to the subject. In spite
of their advantages, microneedle systems are still somewhat
invasive since they involve the extraction of blood from the
patient.
Implanted in vivo sensors provide another means to sample
blood chemistry that does not require blood extraction.
Unfortunately, in vivo sensors interact with the physiology
and are susceptible to degradation during use. It would be
desirable to achieve a less invasive approach that would not
extract blood from the patient and provide longer measure-
ment times than in prior art in vivo devices.
SUMMARY
This invention provides a highly useful device configura-
tion and convenient fabrication process for dense arrays of
microneedles. Unlike the prior art, the invention describes
actuators and sensors associated with each microneedle that
can sample blood chemistry without extraction. The sensing
process is achieved while the needle is inside the patient,
minimizing invasiveness and contamination. Due to their
high multiplicity, needles are actuated in sequence over
extended periods of time, each sensing element being
required to make measurements only over a short timeperiod.
Due to their dense spacing, many measurements may be made
using a single compact array device worn by the subject as a
small patch or chip.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1A is a top cross-sectional view of a microneedle
assembly in accordance with embodiments of the present
invention;
FIG. 1B is a side, cross-sectional view of the microneedle
assembly shown in FIG. 1A;
FIG. 2 is a side, cross-sectional view of a microneedle
assembly with an integral actuator assembly in accordance
with other embodiments of the present invention;
FIG. 3A is a side, cross-sectional view of a microneedle
assembly in accordance with other embodiments of the
present invention;
2
FIG. 3B is a side, cross sectional view of a microneedle
assembly in accordance with yet other embodiments of the
present invention;
FIG. 3C is a top, cross sectional view of the microneedle
5 assembly shown in FIG. 3A;
FIG. 4A is a side, cross-sectional view a portion of a
microneedle assembly;
FIG. 4B is a side, cross-sectional view of portion of another
microneedle assembly,
10	 FIG. 4C is a side, cross-sectional view of a portion of yet
another microneedle assembly;
FIG. 5A is a top view of an alternate configuration of a
microneedle array;
FIG. 5B is a side, cross-sectional view of a microneedle
15 assembly in the microneedle array shown in FIG. 5A; and
FIG. 6 is a side, cross-sectional view of another micron-
eedle array.
DETAILED DESCRIPTION
20
A blood monitoring system in accordance with embodi-
ments of the present invention comprises an integrated circuit
or chip containing a high density array of microneedles in a
patch which is attached to patient and makes multiple blood
25 monitoring measurements. The blood monitoring system
comprises: 1) an array of movable microneedle microma-
chined within associated wells; 2) array of motion actuators
able to move each needle in and out of their associated wells;
3) array of microvalves associated with each microneedle
3o able to control the flow of air around the microneedle; 4) an
array of chemical sensors inserted into patient by movable
microneedles; 5) an array of inductors able to measure chemi-
cal concentration in the vicinity of inserted chemical sensors;
6) conducting vias that provide timed actuating signal signals
35 from a control system to each motion actuator; 7) conducting
vias that transmit signal produced by array of chemical sen-
sors to the control system for processing, although the blood
monitoring system can comprise other numbers and types of
elements in other configurations.
40 FIGS. 1A and 1B show top and side, cross sectional views
of a microneedle configuration. These views depicts micron-
eedle 1 within silicon wafer 2. The microneedle geometry
shown may be achieved using photolithography and other
well known methods in micro fabrication such as Deep Reac-
45 tive Ion Etching (DRIE), although other manufacturing tech-
niques can be used. Microneedle 1 is embedded within well
structure 4, but remains mechanically attached to silicon
wafer 2 through etch stop layer 3 made of materials, such as
silicon dioxide or silicon nitride, although other materials can
5o be used.
The microneedle comprises three elements: an upper nar-
row post 6, a broader lower base 7, and sensing element 8. A
magnified top view of the microneedle assembly is shown in
FIG. IA. Sensing winding 10 is patterned in a coil or spiral
55 geometry on the surface of silicon wafer 2. Sensing winding
10 is addressed by common via 11 and signal via 12. Insulator
13 allows signal via 12 to pass over common via 11 and
sensing winding 10 without electrical shorting. Common via
11 and other signal vias 14 are used to address other micron-
60 eedle assemblies.
A control system comprising a processor with pro-
grammed instructions stored in memory for execution by the
processor of one or more aspects of the present invention as
described herein is coupled to the common via 11 and signal
65 vias 14, although other types of systems could be used. The
control system is used to control the activation of the micron-
eedles and the readings of the sensing windings. The control
US 8,108,023 B2
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system may also process the readings of the sensing windings
to provide an output, such as by way of example only a blood
sugar level reading or another diagnostic result based on the
readings.
FIG. 2 shows a cross section of a microneedle with an
integral actuator assembly 15. Substrate 16 is grooved to
create hollow region 17. Liquid channel 20 fills the grooved
hollow region 17 with a low viscosity liquid such as water.
Resistive element 18 resides within the hollow region 17
along with interconnection electrodes 19. Interconnection
electrodes 19 deliver an actuating signal to resistive element
18 causing it to conduct current and to generate heat. The
heated liquid in the vicinity of creates a vapor bubble 21
which increases the pressure within region 17 as the bubble
expands in volume. The increased pressure in region 17 rup-
tures etch stop layer 3 and drives the microneedle 1 out of its
well structure.
FIGS. 3A-313, show the actuation process for two micron-
eedle configurations. The microneedle shown in FIG. 3A
includes an additional vent slot 22 less than the silicon wafer
thickness in depth. As the vapor bubble expands, it drives
microneedle 1 into subject 23, stopping its travel after the
bottom of base 7 crosses the lower level of vent slot 22. This
distance must be sufficient to allow the microneedle enough
travel into subject 23, where the measurement needs to be
made. For example, in order to measure blood glucose, the
needle must penetrate the stratum commune into the dennis
or epidermis where interstitial fluid orblood is available. This
distance varies according to body location and individual, but
is in the range of 30-200 microns.
Following the heating cycle, the vapor bubble collapses,
thereby decreasing the pressure in region 17. Vent slot 22 is
able to allow air to refill the void created by the collapsing
bubble, thus allowing the microneedle to remain inserted in
subject 23. As a result, sensing element 8 remains in contact
with subject 23, enabling it to sense the desired chemical.
FIG. 3B shows an alternative configuration where the
microneedle inserts sensing element 8 into subject 23. Since
the configuration of FIG. 3B does not have a vent slot 22,
when the bubble collapses during cooling, it pulls the micron-
eedle back toward the silicon wafer. In this case, sensing
element 8 is detachable and remains within subject 23 and,
therefore, should be biologically compatible. Given its small
dimension/volume, the sensor eventually will probably be
absorbed in the body.
FIG. 3A-3C, show how the chemical measurement is
made. Current is driven through sensing windings 10, creat-
ing a magnetic field depicted by field lines 24. Sensing ele-
ments 8 have combined magnetic, inductive, or magnetoelas-
tic properties that vary depending on the chemical
composition of the surrounding region of 23. For example,
sensing elements 8 may comprise a glucose responsive mate-
rial (e.g. a polymer) that changes physical properties depend-
ing on the local glucose concentration. Sensing elements
responsive to other chemicals of interest (e.g. cholesterol)
may also be used.
The glucose responsive material can be configured in a
number of geometries shown in FIGS. 4A-4C. FIG. 4A shows
silicon post 6 holding a two layer system supported by spacer
27, comprising a magnetoelastic layer 25 supporting a glu-
cose responsive polymer layer 26. As layer 26 swells, it gains
mass and volume, hence modifying the resonant frequency of
the mechanically clamped magnetoelastic layer 25. Changes
in resonant frequency of layer 25 are measured by monitoring
the ac impedance of sensing windings 10 and correlated to
glucose concentration. A detachable sensing element may be
achieved by reducing the footprint of spacer 27, modifying its
4
interfacial surface energy relative to post 6, or increasing the
footprint of layer 25 and spacer 27 relative to the width of post
6.
Examples of magnetoelastic materials that can be used for
5 layer 25 include soft magnetic materials with high permeabil-
ity commonly used for transformer cores. Any glucose
responsive polymer such as polyvinyl alcohol (PVA) blends
and composites that change volume or mass as a function of
10 
glucose may be used.
FIG. 4B shows another sensing element comprising a
mechanically resonant nonmagnetic layer 28 supporting a
glucose responsive material with magnetic properties 29, e.g.
a ferrogel. An AC magnetic field 24 sampling 29 in turn
15 induces cyclic forces on layer 28, causing it to resonate at one
or more characteristic frequencies. A change in mass or vol-
ume of the glucose responsive material will modify the over-
all resonant frequency of layers 28 and 29 that is detected by
sensing windings 10.
20 A three-layer system comprising a nonmagnetic resonant
layer 28, a magnetic composite layer 30, and a glucose
responsive material is shown in FIG. 4C. Ferrogel magne-
toelastic layers may also be used in nonresonant conditions
by monitoring changes in impedance of sensing windings 10
25 as a function of ferrogel swelling. A calibration curve relating
resonant frequency versus chemical concentration is needed
for devices shown in FIG. 4A-4C.
FIG. 5A-513 shows an alternate configuration for the
microneedle array where the chemical sensing element is not
30 fabricated integral to the needle. In this case, a thin support
film 32 patterned with sensing elements 33 is aligned with
microneedle array 34 such that each sensing element on film
32 sits over an associated addressable microneedle. Upon
35 actuation, microneedles punch a hole through film 32 and
drive the sensing elements 33 into subject 23. Sensing ele-
ments 33 are left within 23 and continue to be monitored by
the respective sensing winding.
Removal of actuated needles used in configuration 3a may
40 be accomplished as shown in FIG. 6, although other types or
removal systems can be used. In this case, a set of actuated
needles 35 are removed from subject 23 after have completed
their measurement process. To accomplish this, an additional
soft magnetic layer or tape is patterned as pads 36 on the
45 bottom surface of microneedle bases 7. When an external
magnet 37 is placed in proximity to the microneedle array,
each patterned soft magnetic pad 36 magnetizes in a polarity
such that it is attracted toward the external magnet. The attrac-
tive force pulls the microneedle away from subject 23 as
50 shown in FIG. 6. Although the magnet shown is periodically
poled along the array direction, other poling geometries may
be used. Magnet 37 may be brought in contact in a direction
normal to the array surface or moved tangentially along the
surface. The magnetic field will reverse in direction during
55 theprocess butthe force onthemicroneedles will be attractive
toward the magnet. Since magnet 37 will also induce an
attractive force on the unactuated needles, layer 3 provides
mechanical resistance against this motion. Optional mechani-
cal stops 38 may be fabricated onto or as part of substrate 16
60 to enhance the mechanical resistance. Stops 38 must allow for
liquid filling of liquid channels 20.
Although the present invention has been described in con-
siderable detail with reference to certain preferred versions
thereof, other versions are possible. For example, the micron-
65 eedles can be comprised of glass. Therefore, the spirit and
scope of the appended claims should not be limited to the
description of the preferred versions contained herein.
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All features disclosed in the specification, including the
claims, abstract, and drawings, and all the steps in any method
or process disclosed, may be combined in any combination,
except combinations where at least some of such features
and/or steps are mutually exclusive. Each feature disclosed in
the specification, including the claims, abstract, and draw-
ings, can be replaced by alternative features serving the same,
equivalent or similar purpose, unless expressly stated other-
wise. Thus, unless expressly stated otherwise, each feature
disclosed is one example only of a generic series of equivalent
or similar features. Additionally, the recited order of process-
ing elements or sequences, or the use of numbers, letters, or
other designations therefore, is not intended to limit the
claimed processes to any order except as may be specified in
the claims.
Any element in a claim that does not explicitly state
"means" for performing a specified function or "step" for
performing a specified function should not be interpreted as a
"means" or "step" clause as specified in 35 U.S.C. §112.
Accordingly, the invention is limited only by the following
claims and equivalents thereto.
What is claimed is:
1. A blood monitoring system comprising:
a substrate with one or more wells;
one or more needles with one of the needles in each of the
wells;
an actuating system that moves the needles at least partially
out of the wells when activated;
one or more sensors, with one of the sensors on each of the
needles wherein at least one of the sensors comprises a
glucose responsive magnetic material on a mechanically
resonant nonmagnetic layer;
a detection system that reads an output of at least one of the
sensors; and
a control system that controls the activation of the actuating
system and the reading of an output from at least one of
the sensors by the detection system.
2. The system as set forth in claim 1 wherein at least one of
the wells further comprises a vent slot which extends at least
partially along a length of the well.
3. The system as set forth in claim 1 wherein each of the
needles comprises a base connected to an insertion post.
4. The system as set forth in claim 1 wherein the actuating
system comprises:
another substrate with one or more hollow regions,
wherein at least one of the hollow region is positioned
substantially below one of the wells; and
an actuating device in at least one of the hollow regions and
coupled to the control system.
5. The system as set forth in claim 4 wherein the actuating
device comprises a resistive element.
6. The system as set forth in claim 1 wherein at least one of
the sensors is permanently secured to one of the needles.
7. The system as set forth in claim 1 wherein at least one of
the sensors is detachably connected to one of the needles.
8. The system as set forth in claim 1 wherein at least one of
the sensors comprises a glucose responsive material on a
magnetoelastic layer.
9. The system as set forth in claim 1 wherein at least one of
the sensors comprises a glucose responsive polymer layer on
a magnetic composite layer.
10. The system as set forth in claim 1 wherein the detection
system comprises one or more sensing windings with each of
the sensing windings positioned about an opening to each of
the wells.
6
11. The system as set forth in claim 1 further comprising a
retraction system that retracts the activated needles at least
partially back into the wells.
12. The system as set forth in claim 11 wherein the retrac-
5 tion system comprises:
at least one magnetic layer at a base of each of the needles;
and
at least one magnetic source which can be positioned adja-
cent to the base of each of the needles to retract the
10	
activated needles.
13. The system as set forth in claim 12 wherein the retrac-
tion system further comprises one or more stops to prevent the
retraction of needles which have not been activated.
15 14. The system as set forth in claim 1 wherein the actuating
system is configured so that each of the one or more needles
is actuated independently.
15. A method for making a blood monitoring system, the
method comprising:
20 forming one or more needles in a substrate with a well
around each of the needles;
providing an actuating system that move the needles at
least partially out of the wells when activated;
providing one or more sensors on each of the needles;
25 positioning a detection system to read an output of at least
one of the sensors wherein at least one of the sensors
comprises a glucose responsive magnetic material on a
mechanically resonant nonmagnetic layer; and
providing a control system that controls the activation of
30	 the actuating system and the reading of an output from at
least one of the sensors by the detection system.
16. The method as set forth in claim 15 further comprising
providing at least one vent slot which extends at least partially
35 along a length of at least one of the wells.
17. The method as set forthin claim 15 wherein the forming
one or more needles further comprises etching each of the
needles out of the sub strate to comprise abase connected to an
insertion post.
40	 18. The method as set forth in claim 15 wherein the pro-
viding an actuating system comprises:
forming one or more hollow regions in another substrate;
providing an actuating device which is coupled to the
control system in one or more of the hollow regions; and
45	 positioning at least one of the hollow regions substantially
below one of the wells.
19. The method as set forth in claim 18 wherein the actu-
ating device comprises a resistive element.
20. The method as set forth in claim 15 wherein providing
50 one or more sensors on each of the needles further comprises
permanently securing at least one of the sensors to one of the
needles.
21. The method as set forth in claim 15 wherein providing
one or more sensors on each of the needles further comprises55 detachably connecting at least one of the sensors to one of the
needles.
22. The method as set forth in claim 15 wherein at least one
of the sensors comprises a glucose responsive material on a
60 magnetoelastic layer.
23. The method as set forth in claim 15 wherein at least one
of the sensors comprises a glucose responsive material on a
magnetic composite layer.
24. The method as set forth in claim 15 wherein the posi-
65 tioning a detection system further comprises positioning one
or more sensing windings about an opening to one or more of
the wells.
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25. The method as set forth in claim 16 further comprising
providing a retraction system that retracts the activated
needles at least partially back into the wells.
26. The method as set forth in claim 25 wherein the pro-
viding a retraction system further comprises:
attaching at least one magnetic layer at a base of each of the
needles; and
providing at least one magnetic source which can be posi-
tioned adjacent to the base of each of the needles to
retract the activated needles.
8
27. The method as set forth in claim 26 wherein the pro-
viding a retraction system further comprises providing one or
more stops to prevent the retraction of needles which have not
been activated.
28. The method as set forth in claim 15 wherein the actu-
ating system is configured so that each of the one or more
needles is actuated independently.
